The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Quantifying drug release from PLGA nanoparticulates
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452
Alexis, F. (2005) · Polymer International · doi:10.1002/pi.1697 · Cited by 443
Effect of drug type on the degradation rate of PLGA matrices
SIEGEL, S., KAHN, J., METZGER, K., WINEY, K., WERNER, K., & DAN, N. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.06.009 · Cited by 208
Acid- and base-catalyzed hydrolyses of aliphatic polycarbonates and polyesters
Jung, J. H., Ree, M., & Kim, H. (2006) · Catalysis Today · doi:10.1016/j.cattod.2006.02.060 · Cited by 194
Cited by
Polymeric nanoparticles: A study on the preparation variables and characterization methods
Crucho, C. I. C., & Barros, M. T. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.06.004 · Cited by 696
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
Dinarvand, R., Sepehri, N., Manouchehri, Rouhani, & Atyabi, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s18905 · Cited by 453
Xu, Y., Kim, C., Saylor, D. M., & Koo, D. (2017) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.33648 · Cited by 424
Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles
Yoo, J., & Won, Y.-Y. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01228 · Cited by 392
Nanotoxicology and nanoparticle safety in biomedical designs
Biazar, E., Majdi, Zafari, M., Avar, M., Aminifard, S., Zaeifi, D., Ai, Jafarpour, Montazeri, & Gh (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16603 · Cited by 389
Seju, U., Kumar, A., & Sawant, K. K. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.07.025 · Cited by 365
Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles
Vrignaud, S., Benoit, J.-P., & Saulnier, P. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.057 · Cited by 309
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
Zhou, J., Patel, T. R., Sirianni, R. W., Strohbehn, G., Zheng, M.-Q., Duong, N., Schafbauer, T., Huttner, A. J., Huang, Y., Carson, R. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304504110 · Cited by 271
Joshi, S. A., Chavhan, S. S., & Sawant, K. K. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.07.007 · Cited by 235
Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery
Rajapaksa, T. E., Stover-Hamer, M., Fernandez, X., Eckelhoefer, H. A., & Lo, D. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.033 · Cited by 137
“The incomplete release of protein can be due to a several reasons, including, the slow hydrolysis rate of PLGA 85:15 co-polymer which causes the protein to remain in the polymer without being released [45], or non-release of protein due to formation of water-insoluble aggregations of protein inside the nanoparticles […”
Misra, S., Chopra, K., Sinha, V. R., & Medhi, B. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1089956 · Cited by 136
Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection
Steinbach, J. M., Weller, C. E., Booth, C. J., & Saltzman, W. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.008 · Cited by 113
Metadata
- Authors
- Corrigan, O. I., & Li, X.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 37
- Issue
- 3-4
- Pages
- 477-485
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2092970481
- Cited by
- 195
- References
- 4
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.